Startup founded by former Boeing engineers causes shockwaves with new electric boat: 'What you get when you start from scratch'
Electric boat startup Arc has just announced its newest model, the Arc Coast: a center console boat with features from its predecessors but at a significantly lower price.
Mitch Lee and Ryan Cook, both former Boeing engineers, founded the company in 2021 and have already launched two previous models: the Arc One and Arc Sport, according to Electrek.
Those models were priced at $300,000 and $268,000, respectively, but the new 24-foot, all-electric Arc Coast is aimed at a more casual market and is already available for presale starting at $168,000.
Center console boats place the captain at the center, freeing up more space around the edges of the vessel for fishing and relaxation.
The company noted that although the form factor remains popular, it hasn't evolved much, continuing to rely on loud, pollution-spewing engines and cluttered layouts.
"People love center consoles, but the experience hasn't improved," said Mitch Lee, co-founder and CEO of Arc, in a statement.
"The Arc Coast is what you get when you start from scratch: all the benefits of quiet and powerful electric performance, powered by advanced software, and paired with an ownership experience free from many of the headaches common with today's gas boats."
Since these types of vessels tend to have less luxurious upholstery, less protection from the elements, and fewer seating options, the company was able to save money on materials and offer a better price point, Electrek explained.
Boats commonly use diesel to power their engines, but that dirty fuel can contribute to harmful ground-level ozone pollution and lead to fuel spills and oil leaks, which endanger marine environments.
Electrified marine vessels are cleaner and quieter, require less maintenance, and eliminate harmful emissions. Plus, their batteries can be charged with electricity from renewable sources and recycled at the end of their lifecycle.
If you were going to purchase an EV, which of these factors would be most important to you?
Cost
Battery range
Power and speed
The way it looks
Click your choice to see results and speak your mind.
Even when you factor in the 30 million tons of minerals mined annually for lithium-ion batteries, electric vehicles are still better for the environment than mining 16.5 billion tons of fossil fuels to power gas-guzzlers.
The Arc Coast seats up to 10 people on its open deck, and its 226kWh battery should provide approximately four to five hours of cruising at speeds of up to 50 miles per hour, the report detailed.
The battery powers a compact sterndrive rather than the bulky outboards typically used on these vessels, allowing for more room to swim or lounge in the sun.
By reusing the same high-voltage battery system as the Arc Sport, the company says it's bringing the Coast from concept to production in just under one year.
It's expected to release by 2026, and interested buyers can reserve one on the company's website.
Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Here's Why Airbus Shares Took Off Today
A solid performance on orders at the Paris Air Show bolstered prospects at Airbus. The mix of orders was spread across wide-bodies, such as the A350, all the way down to smaller aircraft like the A220. 10 stocks we like better than Airbus SE › Shares in aerospace giant Airbus (OTC: EADSY) rose by as much as 3.1% in early trading as the Paris Air Show concluded for industry professionals (it remains open to the public until Sunday). Airbus had a lot to say and $21 billion in orders to announce , but unfortunately, its great rival, Boeing (NYSE: BA), had very little to say. While Boeing didn't release an official statement on the matter, it's widely reported that Boeing scaled down its participation and elected not to announce new orders following a recent Air India crash involving a Boeing 787 Dreamliner. Boeing had previously announced it would offer full support for the investigation currently taking place. Consequently, Airbus took center stage in the commercial aerospace industry, announcing $14.2 billion in firm orders and a further $6.7 billion under memoranda of understanding (MoUs). Among the 148 firm orders was the first-ever order from LOT Polish Airlines for 40 A220 aircraft. All Nippon Airways, a subsidiary, ordered 27 A321 airplanes. Riyadh Air of Saudi Arabia ordered 25 A350 wide-bodies and will be the first Saudi airline to fly the 350. Vietnam's VietJet signed an MoU for 100 Airbus A321neo aircraft. The strength in A350 (which competes with the Boeing 787) and A321 orders (a highly successful plane Boeing is struggling to compete with) is a continuation of an order trend this year. Meanwhile, the 40 A220 orders are a shot in the arm for an aircraft that Airbus has found it difficult to sign deals on in the last year or so. Overall, it was a positive air show for Airbus, and that's reflected in the stock price today. Before you buy stock in Airbus SE, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Airbus SE wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Here's Why Airbus Shares Took Off Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Hill
7 hours ago
- The Hill
NTSB recommends quick modifications to 737 Max engines
The National Transportation Safety Board (NTSB) on Wednesday recommended that Boeing modify the engines on 737 Max planes due a safety problem caused by bird strikes. The issue came to light during two 2023 flights in Havana, Cuba and New Orleans when smoke filled the cockpit or cabin after a strike, according to the Associated Press. Both Boeing and the Federal Aviation Administration (FAA) warned pilots about the issue, which the NTSB said is caused by a safety feature known as a load reduction device. 'This is a case of an unintended consequence of a new and innovative safety idea where if the fan gets unbalanced that this is a way to alleviate the load and thereby doing less damage to the engine, the engine pylon, all of that,' aviation safety expert John Coxtold the AP. The Commercial Aircraft Corporation of China's C919 planes and Airbus A320neo planes have similar reactions. The engine's manufacturer, CFM International, said the company is working on a software update to mitigate the issue in a joint venture with GE Aerospace and Safran Aircraft Engine. CFM said the current model is 'aligned with the NTSB's recommendations and the work is already underway, in close partnership with our airframers, to enhance the capability of this important system,' per AP. Boeing told The Hill on Friday that they 'support' the NTSB recommendation. The FAA said 'the engine manufacturer develops a permanent mitigation, we will require operators to implement it within an appropriate timeframe,' according to AP. Several 737 pilots told the outlet they were unaware of previous incidents caused by the load reduction device after bird strikes.
Business Wire
8 hours ago
- Business Wire
Archeus Technologies Receives FDA Clearance of Investigational New Drug Application for ART-101 in Development for the Treatment of Prostate Cancer
MADISON, Wis.--(BUSINESS WIRE)-- Archeus Technologies, a company developing radiopharmaceutical therapies for the treatment of patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ART-101, a novel receptor-based targeting small molecule that Archeus has developed for the imaging and treatment of prostate cancer. This IND clearance enables Archeus to initiate a Phase 1 clinical trial in men with metastatic castration-resistant prostate cancer (mCRPC), which is expected to start later this year. ART-101 was discovered and developed by Reinier Hernandez, Ph.D., assistant professor of medical physics at the University of Wisconsin–Madison, with robust development support from the Wisconsin Alumni Research Foundation. The therapy targets prostate-specific membrane antigen (PSMA), similar to several FDA-approved imaging and therapeutic agents. However, preclinical data demonstrates that ART-101 exhibits higher tumor uptake and retention, as well as lower normal tissue and salivary gland uptake, relative to current FDA-approved PSMA-targeting agents. Archeus plans to evaluate ART-101 as a theranostic radiopharmaceutical agent with the potential to deliver alpha particle-emitting isotopes with greater efficacy and safety compared with current standards of care. 'This IND clearance marks an important milestone for Archeus as we prepare to initiate the first of multiple clinical trials set to begin this year from our broader portfolio of differentiated radiopharmaceutical assets for difficult-to-treat cancers,' said Evan Sengbusch, Ph.D., chief executive officer of Archeus Technologies. 'ART-101 represents a promising approach to targeting PSMA-positive prostate cancer with the potential to deliver meaningful clinical benefit and reduced side effects for patients. We are eager to begin evaluating ART-101 in patients to better understand its full therapeutic potential.' In addition, Archeus received IND clearances in October 2024 for its lead therapeutic candidate, ARC-706, and companion diagnostic, ARC-166. The company plans to advance the two assets - together as a theranostic pair - into clinical development this year. Archeus is developing ARC-706 for combination use with certain validated immunotherapies across a range of cancer types. Preclinical data indicate that this radiopharmaceutical agent and treatment paradigm may produce curative responses, as well as immune memory against cancers that are otherwise resistant to these immunotherapies. About Archeus Technologies Archeus Technologies is a company developing radiopharmaceutical therapies for some of the most difficult-to-treat cancers. Starting with its Phase 1-ready therapeutic candidate, ARC-706, the company has assembled a growing pipeline of differentiated radiopharmaceutical therapy agents and companion diagnostic assets with the potential to provide curative responses to patients with advanced cancer. Archeus is led by an executive team with proven radiopharmaceutical expertise and a demonstrated record of advancing innovative agents from discovery through clinical development. In addition, Archeus has a long-standing strategic collaboration with the University of Wisconsin–Madison (UW), a global leader in radiopharmaceuticals and theranostics. To learn more, visit
